Medulloblastoma
Open accessThe DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
Medulloblastoma accounts for nearly 10% of all childhood brain tumors. These tumors occur exclusively in the posterior fossa and have the potential for leptomeningeal spread. Treatment includes a combination of surgery, radiation therapy (in patients >3 years old). Patients >3 years old are stratified based on the volume of postoperative residual tumor and the presence or absence of metastases into “standard risk” and “high risk” categories with long-term survival rates of approximately 85% and 70%, respectively. Outcomes are inferior in infants and children younger than 3 years with exception of those patients with the medulloblastoma with extensive nodularity histologic subtype. Treatment for medulloblastoma is associated with significant morbidity, especially in the youngest patients. Recent molecular subclassification of medulloblastoma has potential prognostic and therapeutic implications. Future incorporation of molecular subgroups into treatment protocols will hopefully improve both survival outcomes and posttreatment quality of life.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Molecular subgroups of medulloblastoma: the current consensus
Taylor, M. D., Northcott, P. A., Korshunov, A., Remke, M., Cho, Y.-J., Clifford, S. C., Eberhart, C. G., Parsons, D. W., Rutkowski, S., Gajjar, A., et al. (2012) · Acta Neuropathologica · doi:10.1007/s00401-011-0922-z · Cited by 1,936 · cited 2×
“Each subgroup was characterized by a unique set of demographic and clinical features, genetics, and gene expression.(14) Identification of molecular subgroup more accurately predicts outcome and clinical behavior than does histopathology or clinical staging.”
Gurney, J. G., Kadan‐Lottick, N. S., Packer, R. J., Neglia, J. P., Sklar, C. A., Punyko, J. A., Stovall, M., Yasui, Y., Nicholson, H. S., Wolden, S., et al. (2003) · Cancer · doi:10.1002/cncr.11095 · Cited by 369
Research works printed but not linked: 108
- 10.1001/archneurpsyc.1925.02200140055002 · DOI · Paper page
- 10.1001/archneur.59.4.642 · DOI
- 10.1001/archneurpsyc.1925.02200140002001 · doi:10.1001/archneurpsyc.1925.02200140002001
- 10.3109/00016925309136718 · DOI · Paper page
- 10.1007/BF00165513 · doi:10.1007/bf00165513
- 10.1016/0277-5379(90)90017-N · DOI · Paper page
- 10.1097/00005072-198301000-00001 · DOI
- 10.1038/415436a · DOI · Paper page
- 10.1007/s00401-014-1291-1 · doi:10.1007/s00401-014-1291-1
- 10.1007/s00401-007-0243-4 · DOI · Paper page
- 10.1148/93.6.1351 · DOI · Paper page
- 10.1200/JCO.2010.30.2299 · DOI · Paper page
- 10.1200/JCO.2013.50.9539 · DOI · Paper page
- 10.1007/s003810100496 · doi:10.1007/s003810100496
- 10.1002/mpo.10121 · DOI
- Ostrom QT, 2015, Neuro Oncol, 16, x1, 10.1093/neuonc/nou327 · DOI · Paper page
- 10.1093/neuonc/nov189 · DOI · Paper page
- 10.1016/j.jocn.2012.04.009 · DOI · Paper page
- 10.1007/s00247-009-1429-9 · doi:10.1007/s00247-009-1429-9
- 10.1148/rg.236035168 · doi:10.1148/rg.236035168
- 10.1002/jmri.22722 · doi:10.1002/jmri.22722
- 10.3174/ajnr.A3990 · DOI · Paper page
- 10.3171/2014.9.PEDS14280 · DOI
- 10.1200/JCO.1999.17.6.1825 · doi:10.1200/jco.1999.17.6.1825
- 10.1159/000120264 · doi:10.1159/000120264
- 10.1200/JCO.2006.06.4980 · DOI · Paper page
- 10.1200/JCO.1999.17.10.3234 · DOI
- 10.1200/JCO.1999.17.3.832 · DOI · Paper page
- 10.1007/BF01404849 · DOI
- 10.3171/jns.1999.91.6.0971 · DOI · Paper page
- 10.1046/j.1365-2559.1999.00577.x · doi:10.1046/j.1365-2559.1999.00577.x
- 10.1002/cncr.10189 · DOI · Paper page
- 10.1093/jnen/62.6.627 · DOI
- 10.1007/s00401-006-0064-x · DOI
- 10.1093/jnen/59.10.857 · DOI · Paper page
- 10.1002/pbc.24002 · doi:10.1002/pbc.24002
- 10.1007/s00381-011-1389-x · doi:10.1007/s00381-011-1389-x
- 10.1016/S1470-2045(13)70449-2 · DOI · Paper page
- 10.1007/s00401-015-1389-0 · DOI
- 10.1038/nature09587 · DOI · Paper page
- 10.1007/s00401-012-0958-8 · DOI · Paper page
- 10.1200/JCO.2012.48.5052 · DOI · Paper page
- 10.1002/cncr.22475 · DOI
- 10.1056/NEJM199503303321302 · DOI · Paper page
- 10.1200/JCO.2014.58.2569 · DOI
- 10.1002/1097-0142(19880515)61:10<1992::AID-CNCR2820611011>3.0.CO;2-J · doi:10.1002/1097-0142(19880515)61:10<1992::aid-cncr2820611011>3.0.co;2-j
- 10.1016/S0360-3016(98)00197-7 · doi:10.1016/s0360-3016(98)00197-7
- 10.1200/JCO.2005.09.095 · DOI · Paper page
- 10.1016/S1470-2045(06)70867-1 · DOI · Paper page
- 10.1016/j.ijrobp.2007.07.2342 · DOI
- 10.1016/S0360-3016(98)00178-3 · doi:10.1016/s0360-3016(98)00178-3
- 10.1200/JCO.2003.11.140 · DOI
- 10.1016/S0360-3016(03)01574-8 · DOI · Paper page
- 10.1097/00130404-200411000-00009 · doi:10.1097/00130404-200411000-00009
- 10.1016/j.ijrobp.2007.02.037 · doi:10.1016/j.ijrobp.2007.02.037
- 10.1016/j.ijrobp.2007.04.052 · doi:10.1016/j.ijrobp.2007.04.052
- 10.1002/ana.410240405 · doi:10.1002/ana.410240405
- 10.1200/JCO.1999.17.7.2127 · DOI · Paper page
- 10.1200/JCO.2003.05.116 · DOI · Paper page
- 10.1200/JCO.2005.00.760 · DOI
- 10.1016/S0360-3016(99)00369-7 · DOI · Paper page
- 10.3171/jns.1994.81.5.0690 · DOI · Paper page
- 10.1016/j.ejca.2004.12.017 · DOI · Paper page
- 10.1200/JCO.2011.40.2792 · DOI · Paper page
- 10.1093/neuonc/nos304 · DOI
- 10.1200/JCO.2008.18.4176 · DOI · Paper page
- 10.1016/S1470-2045(05)70252-7 · DOI · Paper page
- 10.1215/15228517-2008-084 · DOI · Paper page
- 10.1093/neuonc/nor025 · DOI · Paper page
- 10.1056/NEJMoa042176 · DOI · Paper page
- 10.1002/pbc.21525 · DOI · Paper page
- Bowers DC, 2007, J Neurosurg, 107, 5
- 10.1093/neuonc/nop031 · doi:10.1093/neuonc/nop031
- 10.1002/pbc.21655 · doi:10.1002/pbc.21655
- 10.1023/A:1021184400053 · DOI
- 10.1002/cncr.28907 · DOI
- 10.1002/cncr.26148 · DOI
- 10.1002/pbc.25174 · DOI
- 10.1007/s00381-012-2013-4 · doi:10.1007/s00381-012-2013-4
- 10.1200/JCO.1996.14.6.1922 · DOI
- 10.1215/15228517-2008-044 · doi:10.1215/15228517-2008-044
- 10.1200/JCO.1998.16.1.222 · DOI
- 10.1200/JCO.1998.16.7.2486 · DOI
- 10.1016/j.ijrobp.2014.01.013 · DOI
- 10.1159/000120761 · DOI
- 10.1159/000028848 · DOI
- 10.1016/j.ijrobp.2009.04.058 · doi:10.1016/j.ijrobp.2009.04.058
- Robertson PL, 2006, J Neurosurg, 105, 444
- 10.1093/neuonc/nos160 · DOI
- 10.1093/brain/awp241 · DOI
- 10.1227/00006123-198411000-00014 · DOI · Paper page
- 10.1016/0090-3019(91)90094-P · DOI
- 10.1200/JCO.2003.01.202 · DOI · Paper page
- 10.1016/j.ijrobp.2013.03.034 · DOI · Paper page
- 10.1212/WNL.0b013e3181c17ea8 · DOI
- 10.1093/neuonc/nos267 · DOI · Paper page
- 10.1002/mpo.10105 · DOI
- 10.1007/BF03259853 · DOI · Paper page
- 10.1212/WNL.34.7.934 · DOI · Paper page
- 10.1016/j.ejca.2003.08.009 · DOI · Paper page
- 10.1200/JCO.2004.00.5355 · DOI · Paper page
- 10.1007/s00381-014-2388-5 · DOI
- 10.3171/jns.2003.99.2.0280 · doi:10.3171/jns.2003.99.2.0280
- 10.1007/s11060-013-1213-4 · DOI
- 10.1007/s11060-013-1347-4 · doi:10.1007/s11060-013-1347-4
- 10.1002/cncr.22129 · doi:10.1002/cncr.22129
- 10.1016/j.ijrobp.2013.11.239 · doi:10.1016/j.ijrobp.2013.11.239
- 10.1158/1078-0432.CCR-13-1425 · DOI · Paper page
Cited by
The role of SOX family members in solid tumours and metastasis
Grimm, D., Bauer, J., Wise, P., Krüger, M., Simonsen, U., Wehland, M., Infanger, M., & Corydon, T. J. (2020) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.03.004 · Cited by 487
Juraschka, K., & Taylor, M. D. (2019) · Journal of Neurosurgery: Pediatrics · doi:10.3171/2019.5.peds18381 · Cited by 275
Medulloblastoma: Molecular understanding, treatment evolution, and new developments
Liu, X., Ding, C., Tan, W., & Zhang, A. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107516 · Cited by 54
Gangwani, K., Lu, C., Dhanda, S. K., Sioson, E., Zaldívar Peraza, A., Matt, G. Y., Paul, R., Wang, J., Reilly, C., Acić, A., et al. (2025) · Cancer Research · doi:10.1158/0008-5472.can-24-4976 · Cited by 1
Metadata
- Authors
- Millard, N. E., & De Braganca, K. C.
- Venue
- Journal of Child Neurology
- Publisher
- SAGE Publications
- Published
- 2016-07-20
- Volume
- 31
- Issue
- 12
- Pages
- 1341-1353
- ISSN
- 0883-0738 (ISSN-L)
- 1708-8283
- OpenAlex
- W4252935772
- Cited by
- 247
- References
- 2
- FWCI
- 2.45
- Type
- journal article
- Language
- en
- Update notices
- correction (2016-09-15)
- Open access
- green
- Licence
- journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.